Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 6;4(6):1035-1045.
doi: 10.1002/rth2.12347. eCollection 2020 Aug.

Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity

Michael Wang  1 , Michael Recht  2 , Neeraj N Iyer  3 , David L Cooper  3 , J Michael Soucie  4
Affiliations

Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity

Michael Wang et al. Res Pract Thromb Haemost. .

Abstract

Background: Recurrent joint bleeding in hemophilia results in arthropathy and functional impairment. The relationship of arthropathy development and factor activity (FA) has not been reported in patients with FA levels <15%-20%.

Methods: During the Centers for Disease Control and Prevention Universal Data Collection, joint range-of-motion (ROM) measurements were taken at each comprehensive visit. Data were extracted from male patients with hemophilia (PWH) age ≥2 years with baseline factor activity levels ≤40%, excluding those prescribed prophylaxis, and used to calculate a proportion of normal ROM (PN-ROM) measure. Data were analyzed using regression models.

Results: There were 6703 eligible PWH with 30 102 visits. PN-ROM declined with increasing age, and was associated with hemophilia severity, race/ethnicity, obesity, and viral illnesses. PWH ≥30 years old with fFA ≤2% and those ≥50 years old with FA ≤5% had mean PN-ROM values >10% less than controls; those ≥40 years old with FA <1% had values >20% less than controls. In the multivariable analysis, subjects with <1% FA had a 0.43% greater decrease (-0.49 to -0.37, 95% confidence interval) in PN-ROM each year relative to those with 16%-40% factor activity. A less pronounced effect was seen with 1%-5% or 6%-9% FA.

Conclusion: The effect of FA on ROM loss is far greater than that of any of the other characteristics, especially with FA <10%. This emphasizes the need to maintain a high index of suspicion for arthropathy in individuals with moderate and low-mild hemophilia.

Keywords: arthropathy; clotting factor; hemophilia; joint disease; range of motion.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Average ROM proportion by age group based on baseline factor levels in patients not receiving prophylactic treatment of bleeding: (A) 4807 males with hemophilia A; (B) 1896 males with hemophilia B. FIX, factor IX; FVIII, factor VIII; ROM, range of motion
See this image and copyright information in PMC

References

    1. Srivastava A, Brewer AK, Mauser‐Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1–47. - PubMed
    1. Centers for Disease Control and Prevention HTC Population Profile ‐ January 2012 to March 2019. 2019. [Accessed 2017 September 7] Available from: https://www.cdc.gov/ncbddd/hemophilia/communitycounts/data‐reports/2019‐3
    1. Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia. 2006;12(suppl 3):117–21. - PubMed
    1. National Hemophilia Foundation Medical and Scientific Advisory Council Recommendation #241 Concerning Prophylaxis ‐ Regular Administration of Clotting Factor Concentrate to Prevent Bleeding. www.hemophilia.org: National Hemophilia Foundation; February 27, 2016. [Accessed 2017 July 26] Available from: https://www.hemophilia.org/sites/default/files/document/files/241Prophyl....
    1. Manco‐Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–44. - PubMed